CoronaryAtlas logo
CoronaryAtlas
ASCVD Risk Atlas
← Back to table
C

Vascular (endothelial) dysfunction

Imaging & Subclinical DiseasePhysical parameterriskpartially modifiable
15
evidence score

Also known as: Vascular dysfunction, vascular dysfunction

PREVENT status

Not a PREVENT input variable.

Causal support

trial evidence

Score components
lit volume: 3meta-analyses: 0trials: 12genetic: 0MR bonus:

References (1)

0 meta-analyses / systematic reviews

Clinical trials (15)

NCTTitleStatusTypeInterventions
NCT06600178Innovative Therapy to Treat Women With Angina With Nonobstructive Coronary Artery Disease (ANOCA) and Coronary Microvascular DiseaseRECRUITINGINTERVENTIONALBrezavvy 20Mg Oral Tablet, Placebo
NCT06681896Microvascular Coronary Rehabilitation For Improving Treatment - Feasibility StudyRECRUITINGINTERVENTIONALMICROFIT - personalised high intensity interval training exercise rehabilitation and dietary advice
NCT06683131IMpact of PCSK9 inhibitoR initiatiOn Before Percutaneous Coronary Intervention on Coronary microVascular Dysfunction and Events for Acute Myocardial Infarction: a Multi-center, Open-label, Randomized, Controlled TrialNOT YET RECRUITINGINTERVENTIONALTafolecimab
NCT06217120Reversing Microvascular Dysfunction in Heart Failure With Ejection Fraction > 40% Using Colchicine (The COL-Micro-HF Study)UNKNOWNINTERVENTIONALColchicine, Placebo
NCT05294887First Prospective Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease After Coronary Physiological TestingUNKNOWNINTERVENTIONALBisoprolol, Diltiazem, Placebo
NCT04338165Effect of Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography : a Monocentric, Prospective, Randomized and Open-label Phase II TrialUNKNOWNINTERVENTIONALEvolocumab 140 MG/ML [Repatha]
NCT04777045Efficacy of Diltiazem to Improve Coronary Microvascular Dysfunction: a Randomized Clinical TrialACTIVE NOT RECRUITINGINTERVENTIONALDiltiazem Hydrochloride, Placebo
NCT03829046The Effects of Evolocumab on Endothelial and Inflammatory Biocellular Markers in Patients With Diabetes and Atherosclerotic Vascular Disease (METCHNIKOFF)COMPLETEDINTERVENTIONALPlacebo, Evolocumab
NCT02910154Comprehensive Treatment of Angina in Women With Microvascular Dysfunction - a Proof of Concept Study of the iPower CohortCOMPLETEDINTERVENTIONALDiet, Training, Medication (with statin and ACE-inhibition)
NCT02602600Effect of Glucagon-like Peptide-1 Stimulation on Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Obstructive Stenosis of Major Coronary VesselsCOMPLETEDINTERVENTIONALLiraglutide
NCT02660047Magnetic Resonance Assessment of Victoza Efficacy in the Regression of Cardiovascular Dysfunction In Type 2 Diabetes Mellitus and South Asian DescentCOMPLETEDINTERVENTIONALLiraglutide, Liraglutide - Placebo
NCT02628301Is Microvascular Dysfunction an Early Phenomenon in the Development of Skeletal Muscle Insulin Resistance? A Dietary Intervention Study in Healthy MenCOMPLETEDINTERVENTIONALHypercaloric diet, Normocaloric diet
NCT06076551Sex Difference of Coronary Microvascular Dysfunction Evaluated by Coronary Flow Reserve in Patients With Non-obstructive Coronary Artery DiseaseRECRUITINGOBSERVATIONALAdenosine stress echocardiography
NCT03132129Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes MellitusRECRUITINGOBSERVATIONALCardiovascular magnetic resonance (CMR) imaging and magnetic resonance spectroscopy, Transthoracic echocardiography, Computed tomography coronary artery calcium scoring
NCT07363187Evaluation of Microvascular Changes by Nailfold Capillaroscopy and Serum ADMA, Von Willebrand Factor, Hs-CRP, and D-dimer Levels in Healthcare Workers Exposed to Chronic Low-Dose Ionizing RadiationNOT YET RECRUITINGOBSERVATIONAL

Genetic associations (0)

None linked.